Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)

TRCK

Johnson & Johnson’s Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer’s Disease

TRCK

Calibre Delivers Record Q4 Gold Production of 76,269 Ounces; 2025 Gold Production Expected to Significantly Increase as Valentine Gold Mine, Canada Remains on Track for First Gold During Q2, 2025

TRCK

Dutch Bros Rolls Out Cereal Beverages, On Track With Growth Efforts

TRCK

Is Mondelez on Track for Success Despite Near-Term Challenges?

Continuous reinvestments in brands and impressive portfolio reshaping efforts place MDLZ for growth amid cost and global challenges.

This website automatically aggregates content from various other websites. The copyright of content and images belongs to those websites and their respective companies. We are not responsible for the content published here. Please ensure that all information is for reference only and not investment advice. However, we will strive to strictly control content that provides no value or brings negativity to the community.

No Result

View All Result

Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)

Johnson & Johnson’s Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer’s Disease

Calibre Delivers Record Q4 Gold Production of 76,269 Ounces; 2025 Gold Production Expected to Significantly Increase as Valentine Gold Mine, Canada Remains on Track for First Gold During Q2, 2025

Dutch Bros Rolls Out Cereal Beverages, On Track With Growth Efforts

TRCK

Is Mondelez on Track for Success Despite Near-Term Challenges?

Recent Posts

Recent Comments